Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Oelke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Arthritis and Rheumatism|July 13, 2002
Pathogenesis of lupusKurt Oelke, Bruce Richardson
International Reviews of Immunology|June 19, 2004
Decreased T cell ERK pathway signaling may contribute to the development of lupus through effects on DNA methylation and gene expressionKurt Oelke, Bruce Richardson
Arthritis and Rheumatism|June 10, 2004
Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitorsKurt Oelke, Qianjin Lu, Derek Richardson, et al.
Arthritis Research & Therapy|November 3, 2023
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trialsJohn Tesser, Ahmet Gül, Ewa Olech, et al.
Rheumatology and Therapy|July 14, 2026
Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF InhibitorChristina Charles-Schoeman, Kurt Oelke, Patrick M Zueger, et al.
Arthritis Care & Research|October 26, 2012
Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label studyPeter Nash, Sauithree Nayiager, Mark C Genovese, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Arthritis and Rheumatism|July 13, 2002
Pathogenesis of lupusKurt Oelke, Bruce Richardson
International Reviews of Immunology|June 19, 2004
Decreased T cell ERK pathway signaling may contribute to the development of lupus through effects on DNA methylation and gene expressionKurt Oelke, Bruce Richardson
Arthritis and Rheumatism|June 10, 2004
Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitorsKurt Oelke, Qianjin Lu, Derek Richardson, et al.
Arthritis Research & Therapy|November 3, 2023
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trialsJohn Tesser, Ahmet Gül, Ewa Olech, et al.
Rheumatology and Therapy|July 14, 2026
Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF InhibitorChristina Charles-Schoeman, Kurt Oelke, Patrick M Zueger, et al.
Arthritis Care & Research|October 26, 2012
Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label studyPeter Nash, Sauithree Nayiager, Mark C Genovese, et al.
Pageof 1